Retatrutide Peptide — GLP-1 Triple Agonist, Metabolic Research Profile | Peptalies

A detailed overview of Retatrutide (LY3437943): the mechanism of GIP/GLP-1/glucagon triple agonism, preclinical data on metabolic mechanisms, and why it is a leading metabolic research peptide in 2026.